ICU Decoded › Library › ICU Decoded chapters › Endocrine, Metabolic & Toxicology › Insulin & Glycemic Targets
Insulin & Glycemic Targets
Endocrine, Metabolic & Toxicology · ICU Decoded chapter 63 · Free in full
Cited to NICE-SUGAR evidence base .
Key points
Target 140–180 mg/dL (7.8–10 mmol/L); tight control (80–110) increases hypoglycemia and mortality.
Protocolized IV insulin infusion in the critically ill; capillary glucose q1h until stable.
For hypoglycemia <70, give 20–25 g IV dextrose and recheck in 15 min.
Switch to SC basal-bolus once eating/stable.
Continue IV insulin until DKA has resolved; start the basal-insulin overlap 1–2 hours before stopping the infusion.
Pathways
Adjusting the Insulin Infusion
STEP 1 — Check the current blood glucose (BG) and the hourly rate of change
BG <70 mg/dL?
Manage as hypoglycemia: 20–25 g IV dextrose, recheck in 15 min, then adjust the infusion per protocol
Titrate the IV insulin infusion per the locally validated protocol, targeting 140–180 mg/dL; check BG q1h until stable
In DKA never reduce the insulin infusion below 1 U/h; start SC basal insulin with a 1–2 h overlap before stopping the infusion
BG stable in target on a low infusion rate, and the patient eating?
Transition to SC basal-bolus insulin with a 1–2 h overlap before discontinuing the infusion
Continue the infusion; reassess hourly
Table-driven protocols (e.g., the Yale regimen) vary between institutions — follow the locally validated version
← DKA & Hyperosmolar State · Thyroid Storm & Myxedema →
More in Endocrine, Metabolic & Toxicology
Part of ICU Decoded — open the interactive version .